Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL)

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 113-114

  Gupta, Vikas ^a   Yi, Qi Long ^b   Brandwein, Joseph ^a   Lipton, Jeffrey H ^a   Messner, Hans A ^a   Schuh, Andre C ^a   Wells, Richard A ^a   Minden, Mark D ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Consolidation; Survival

Indexed keywords

CYTARABINE; DAUNORUBICIN; RETINOIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONVALESCENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE; TRETINOIN;

EID: 8444235382     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.006     Document Type: Article

References (7)

1. Sanz M.A., Martin G., Gonzalez M., Leon A., Rayon C., Rivas C., et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood. 103:2004;1237
2. Fenaux P., Chastang C., Chevret S., Sanz M., Dombret H., Archimbaud E., et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood. 94:1999;1192
3. Sanz M.A., Martin G., Rayon C., Esteve J., Gonzalez M., Diaz-Mediavilla J., et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood. 94:1999;3015
4. Tallman M.S., Andersen J.W., Schiffer C.A., Appelbaum F.R., Feusner J.H., Woods W.G., et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood. 100:2002;4298
5. Hu Z.B., Minden M.D., McCulloch E.A. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. Leukemia. 10:1996;410
6. Bourgeois E, Chevret S, Sanz M, Dombret H, Thomas X, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Degos L, Fenaux P, Long term follow up of APL treated with ATRA and chemotherapy (CT) including incidence of late relapses and overall toxicity. Blood 2003;102:140a (abstract 483).
7. Avvisati G, Petti MC, Lo Coco F, Testi AM, Fazi P, Specchia G, Malagola M, Di Bona E, Recchia A, Marmont F, Buelli M, Lazzarino M, Raimondo FD, Leoni F, Kropp MG, Veneri D, Miccolis I, Rossi G, Venditti A, Mandelli F, AIDA: The Italian way of treating Acute Promyelocytic Leukemia (APL), Final Act. Blood 2003;102:142a (abstract 487).